Literature DB >> 26234796

Role of the heme oxygenase-adiponectin-atrial natriuretic peptide axis in renal function.

Joseph Fomusi Ndisang1.   

Abstract

The incidence of renal complications including kidney failure is on the rise. Moreover, with aging of the population and the high incidence of diabetes, hypertension and obesity, this trend may prevail. An important cytoprotective enzyme that has been shown to improve renal function is heme-oxygenase (HO). HO is known to abate apoptosis and necrosis, and improves cell vitality, which in turn, may enhance tissue regeneration. Consistently, HO has been shown to restore tissue morphology by potentiating potentiate proteins of repair/regeneration and promoting neovascularization. The formation of new tissue may replace damaged or dysfunctional tissue to preserve cellular integrity and function after injury. Emerging evidence indicate that HO-inducers improve kidney function in several models including, (i) streptozotocin-induced diabetic rats, (ii) Zucker-diabetic-fatty rats, (iii) Zucker-fatty rats, (iii) spontaneously hypertensive rats, (iv) uninephrectomized deoxycorticosterone-acetate hypertensive rats, (v) N(ω)-nitro-l-arginine-methyl ester (L-NAME)-induced hypertensive rats, (vi) glycerol induced renal failure, (vii) nephrotoxic nephritis, (viii) sepsis-induced kidney injury, (ix) cystic renal disease, (x) cisplatin-mediated acute kidney injury, and (xi) rhabdomyolysis-induced renal injury. The mechanisms underlying the HO-mediated reno-protection include: (i) the restoration of renal morphology by enhancing proteins of regeneration, (ii) the potentiation of the HO-adiponectin-atrial natriuretic peptide axis, with corresponding suppression of oxidative/inflammatory insults and extracellular matrix/profibrotic factors, and (iii) the potentiation of podocyte cytoskeletal proteins such as nephrin, podocin, podocalyxin and CD2-associated-protein, which are fundamental for forming the glomerular filtration barrier that selectively allows small molecules to pass through but not large protein molecules. Thus, this review highlights the HO-adiponectin-atrial natriuretic peptide axis in renoprotection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26234796     DOI: 10.2174/1381612821666150803145508

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  Phenotypic Characterization of Macrophages from Rat Kidney by Flow Cytometry.

Authors:  Alfonso Rubio-Navarro; Melania Guerrero-Hue; Beatriz Martín-Fernandez; Isabel Cortegano; Elena Olivares-Alvaro; Natalia de Las Heras; Mario Alía; Belén de Andrés; María Luisa Gaspar; Jesús Egido; Juan Antonio Moreno
Journal:  J Vis Exp       Date:  2016-10-18       Impact factor: 1.355

2.  Sex-Dependent Effects of HO-1 Deletion from Adipocytes in Mice.

Authors:  Peter A Hosick; Mary Frances Weeks; Michael W Hankins; Kyle H Moore; David E Stec
Journal:  Int J Mol Sci       Date:  2017-03-11       Impact factor: 5.923

3.  Adiponectin Inhibits LPS-Induced HMGB1 Release through an AMP Kinase and Heme Oxygenase-1-Dependent Pathway in RAW 264 Macrophage Cells.

Authors:  Mohamed Elfeky; Ryuji Kaede; Yuko Okamatsu-Ogura; Kazuhiro Kimura
Journal:  Mediators Inflamm       Date:  2016-05-30       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.